J7527 – Everolimus, oral, 0.25 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ7527
- Long description
- Everolimus, oral, 0.25 mg
- Short description
- Oral everolimus
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1GImmunizations/Vaccinations- Added
- January 1, 2013
- Last change
- January 1, 2014 – No change
Frequently asked questions
What is HCPCS code J7527?
J7527 is a HCPCS Level II code for everolimus, oral, 0.25 mg.
Does Medicare cover J7527?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J7517 – Mycophenolate mofetil, oral, 250 mg
- J7518 – Mycophenolic acid, oral, 180 mg
- J7519 – Injection, mycophenolate mofetil, 10 mg
- J7520 – Sirolimus, oral, 1 mg
- J7521 – Tacrolimus, granules, oral suspension, 0.1 mg
- J7524 – Mycophenolate mofetil, oral, 5 mg
- J7525 – Tacrolimus, parenteral, 5 mg
- J7526 – Injection, mycophenolate mofetil, 5 mg
- J7528 – Mycophenolate mofetil, for suspension, oral, 100 mg
- J7529 – Mycophenolate mofetil, for suspension, oral, 5 mg
- J7530 – Mycophenolate mofetil (myhibbin), oral suspension, 5 mg
- J7531 – Prednisolone sodium phosphate, orally disintegrating tablet, 1 mg
- J7599 – Immunosuppressive drug, not otherwise classified
- J7601 – Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
- J7604 – Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
- J7605 – Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.